ROLE OF HERBAL FORMULATION OF GARLIC ON LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES RELATED DYSLIPIDEMIA

被引:0
|
作者
Siddiqui, Naveed Ali [1 ]
Haider, Saida [1 ]
Misbah-ur-Rehman, Mohammad [2 ]
Perveen, Tahira [1 ]
机构
[1] Univ Karachi, Dept Biochem, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
来源
PAKISTAN HEART JOURNAL | 2016年 / 49卷 / 04期
关键词
Lipid profile; dyslipidemia; herbal product; garlic;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the role and side effects of garlic on lipid profile in diabetic dyslipidemic patients along with their lipid lowering efficacy. Methodology: This cross sectional study was carried out at Surgeon Munawar Memorial Hospital Bahadurabad Karachi. The study period consisted of 8 weeks st st from 1 February 2015 to 31 March 2015. Patients with age between 30 and 60 years of either gender with diabetic dyslipidemia were included. The exclusion criteria included pregnant/lactating females, liver, renal and established coronary artery disease or ischemic heart disease. Results: Total of 30 diabetic dyslipidemic patients with abnormal lipid profile were included. Patients were orally administered with local herbal product of garlic (300 mg/day) for 8 weeks. Serum levels of cholesterol, high density lipoprotein (HDL), triglyceride (TG), and low density lipoprotein (LDL) were estimated in patients before and after treatment with local herbal product of garlic (300 mg/day). After the treatment of garlic, serum cholesterol and low density lipoprotein were significantly decreased but there was no effect on triglyceride levels (p > 0.05). Conclusion: On the basis of this study we concluded that herbal products like garlic significantly decreases cholesterol, low density lipoprotein (LDL) and increases high density lipoprotein (HDL).
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [21] Serum Iron Concentration and Lipid Profile in Type 2 Diabetes Patients
    Mandal, Sacira
    [J]. GLASNIK HEMICARA I TEHNOLOGA BOSNE I HERCEGOVINE, 2020, (54): : 7 - 12
  • [22] Dapagliflozin Effects on the Lipid Profile of Patients With Type 2 Diabetes Mellitus
    Hardy, Elise
    Ptaszynska, Agata
    De Bruin, Tjerk W. A.
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    [J]. DIABETES, 2013, 62 : A310 - A310
  • [23] The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia
    Abdel-Gayoum, AGA
    [J]. SAUDI MEDICAL JOURNAL, 2004, 25 (02) : 207 - 211
  • [24] Dyslipidemia-related memory impairment in type 2 diabetes
    Miclea, S.
    Hancu, N.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 402 - 402
  • [25] DYSLIPIDEMIA IN PATIENTS WITH OSTEOARTHRITIS AND TYPE 2 DIABETES MELLITUS
    Oliinyk, M.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S400 - S400
  • [26] Adiponectin and dyslipidemia in Caribbean patients with type 2 diabetes
    Foucan, L.
    Larifla, L.
    Deloumeaux, J.
    Maimaitiming, S.
    Velayoudom, F. -L.
    Hedreville, S.
    Blanchet, A.
    Bangou, J.
    Ezourhi, N.
    Aubert, R.
    Benabdallh, S.
    Marianne-Pepin, T.
    Rock, F.
    Donnet, J. -P.
    Fumeron, F.
    [J]. DIABETES & METABOLISM, 2011, 37 : A76 - A77
  • [27] Treating dyslipidemia in patients with type 2 diabetes mellitus
    Frank, Michelle L.
    Gerhardt, Annie M.
    [J]. NURSE PRACTITIONER, 2015, 40 (08): : 18 - 22
  • [28] Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan
    Abdel-Aal, Nazik M.
    Ahmad, Azmi T.
    Froelicher, Erika S.
    Batieha, Anwar M. S.
    Hamza, Musdaq M.
    Ajlouni, Kamel M.
    [J]. SAUDI MEDICAL JOURNAL, 2008, 29 (10) : 1423 - 1428
  • [29] Optimal treatment of dyslipidemia in patients with type 2 diabetes
    Taskinen, MR
    [J]. ATHEROSCLEROSIS: RISK FACTORS, DIAGNOSIS, AND TREATMENT, 2002, : 497 - 497
  • [30] The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
    Irini P. Chatziralli
    [J]. Diabetes Therapy, 2017, 8 : 209 - 212